CONTACT US
Events
Events

Meet the Precision
AQ team at
ISPOR Europe 2026

Booth #: 918

Vienna, Austria | 8-11 November, 2026

ISPOR EU 2026

Schedule time to meet our HEOR & Access Strategy team at ISPOR Europe 2026 in Vienna, Austria, from 8-11 November 2026. 

Whether it’s building the right evidence or refining your value story, we’re here to simplify the journey from development to patient care – so your therapies can reach the patients who need them most. 

Complete the form to book a meeting, and we’ll reach out to confirm the details. 

Explore Precision AQ Research at ISPOR EU 2026

Discover 30+ posters, podium presentations, and workshops covering HTA, JCA. market access, evidence synthesis, pricing policy, and payer insights shaping healthcare decision-making across global markets. Download the research overview.

Meet Our Global HEOR & Access Strategy Team

Lance Grady_AQ_full Lance Grady_AQ-full-bw

Lance Grady

EVP, Managing Partner,
Global HEOR & Access Strategy

Ross Maclean Ross Maclean-BW

Ross Maclean, MD

EVP, Partner,
Global HEOR & Access Strategy

Leanne Larson Leanne Larson-BW

Leanne Larson, MHA

SVP, Managing Director, Evidence Generation,
HEOR

Emma Hawe_AQ-sm Emma Hawe B&W

Emma Hawe, MSc

SVP, Managing Director, Evidence Synthesis and Decision Modeling,
HEOR

Alex Grosvenor_AQ_full AQ_GlobalAccess_AlexGrosvenor_bw-2

Alex Grosvenor

SVP, Managing Director,
Global Access Strategy

Jeroen Jansen_AQ-full Jeroen Jansen_AQ-full-bw

Jeroen Jansen, PhD

Chief Scientist,
HEOR

AQ_GlobalAccess_RichardMacCaulay AQ_GlobalAccess_RichardMacCaulay_bw

Richard Macaulay, PhD

Senior Vice President,
Global Access Strategy

Steeve Steeve.black and white

Steeve Lamontagne, MSc

Senior Vice President,
Business Development

Andrew Frederickson-2 Andrew Frederickson-BW-1

Andrew Frederickson, MS

Vice President,
HEOR

Alicia Pepper-1 Alicia Pepper-BW

Alicia Pepper, PhD

Vice President,
HEOR

Andrea Berardi_AQ-full-1 Andrea Berardi_AQ-full-1 - Edited

Andrea Berardi, MSc

Vice President,
HEOR

AQ_GlobalAccess_DavidCarr-1 AQ_GlobalAccess_DavidCarr_bw-1

David Carr, PhD

Vice President,
Global Access Strategy

Melissa Maravic_AQ-1 Melissa Maravic BW-1

Melissa Maravic, PhD

Vice President,
HEOR

Schedule a Meeting

Explore our blog

Prelaunch Product Evaluations: When Label-Based Assumptions Don't Tell the Whole Story

Prelaunch Product Evaluations: When Label-Based Assumptions Don't Tell the Whole Story

September 25, 2026

Mechanism of Action: Step Up & Be Heard in Rare Disease

Mechanism of Action: Step Up & Be Heard in Rare Disease

In a crowded market, your drug’s mechanism of action (MOA) is more than a scientific formality – it’s strategic....

September 14, 2026

Allowing Access Versus Driving Access: A New Challenge for Health Systems

Allowing Access Versus Driving Access: A New Challenge for Health Systems

Author: Kelly Gaffney, PharmD, BCOP, DPLA, Senior Director, Access Experience Team

September 11, 2026